Medicine + House
Atul Kumra
CEO
CEO
Worldwide Pharmaceuticals
MEDICINE HOUSE was founded in 1987 as a wholesale and distributing company in New Delhi to provide access to treatment options for hospitals and individual patients that were not available in India at that time for better healthcare.
In a short span of time Medicine House became the source for Life Saving and CriticalCare medicines not just in India but parts of Asia, Middle East, Japan and the Africanregion. As our sourcing network increased, we were able to offer the latest medicinesworldwide regardless of their origin country.
Import of Pharmaceuticals (Generics & Branded)
- Reference Listed Drugs (RLD) Sourcing
- Comparator Drugs Sourcing
- Named Patient Imports
Our Specialty pharmaceuticals sourcing network has developed over the past 33+years. Our network is built over years of experience and trusted relationships with manufacturers and distributors worldwide. IF IT IS AVAILABLE IN THE WORLD, WE CAN SOURCE IT FOR YOU. We are serving Clinical Research Organizations, Hospitals, Medical Institutions, Individual Patients and Healthcare Practitioners in over 25 countries with specialty medicines, comparator drugs and RLD’s. We have helped over 70,000 patients worldwide with their medications and continue to provide our experienced helping hand in making sure that the patients and healthcare providers have access to the latest and the best treatment options for their unmet medical treatment needs, regardless of their location or limited access to the new treatment options available in other parts of the world.
- Certificates (COA & COC)
- Validated Packaging to ensure product integrity during transportation.
- Temperature Control Data Loggers for Cold chain products
- 72-120 Hours Delivery Time (In most cases, If the delivery time for a hard to source product is more than 72 hours, a team member will inform you in advance)
₹
Verzenio (abemaciclib) is a medication indicated for the treatment of women with HR-positive, HER2-negative advanced or metastatic breast cancer. Detailed product information for the Medical Professional is available at https://www.verzenio.com/
Verzenio (abemaciclib) is a medication indicated for the treatment of women with HR-positive, HER2-negative advanced or metastatic breast cancer. Detailed product information for the Medical Professional is available at https://www.verzenio.com/
Ibrance (palbociclib) is a medication used for the treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer. Detailed product information for the Medical Professional is available at https://www.ibrance.com/
Ibrance (palbociclib) is a medication used for the treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer.
Ibrance (palbociclib) is a medication used for the treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer. Detailed product information for the Medical Professional is available at https://www.ibrance.com/
Keytruda (pembrolizumab) is a medication used for the treatment of advanced melanoma, metastatic nonsquamous NSCLC, recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC), recurrent classical Hodgkin Lymphoma (cHL), locally advanced or metastatic urothelial carcinoma, solid tumours having the biomarkers MSI-H or dMMR, recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, triple-negative breast cancer. Detailed product information for the Medical Professional is available at https://www.keytruda.com/
Kisqali (ribociclib) is a medication used, in combination with an aromatase inhibitor as initial endocrine-based therapy, for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. Detailed product information for the Medical Professional is available at https://www.us.kisqali.com/metastatic-breast-cancer/
Lynparza (olaparib) is a medication used for the treatment of ovarian, fallopian tube, primary peritoneal cancer, prostate cancer, prostate cancer and breast cancer. Detailed product information for the Medical Professional is available at https://www.lynparza.com/
Perjeta (pertuzumab) is a medication used for the treatment of HER2 positive breast cancer in patients with metastatic cancer or as neoadjuvant treatment for patients with locally advanced, inflammatory, or early stage breast cancer as part of a complete treatment regimen for early breast cancer. Detailed product information for the Medical Professional is available at https://www.perjeta.com/
Tecentriq (atezolizumab) is a medication used for the treatment of locally advanced or metastatic urothelial carcinoma, for the treatment of metastatic non-small cell lung cancer (NSCLC), and for the treatment of advanced triple negative breast cancer (TNBC). Detailed product information for the Medical Professional is available at https://www.tecentriq.com/
Talzenna (talazoparib) is a medication used for the treatment of adult patients with deleterious or suspected deleterious germline breast cancer susceptibility gene (BRCA)-mutated (gBRCAm) human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer. Detailed product information for the Medical Professional is available at https://www.talzenna.com/
Xeloda (capecitabine) is indicated for the treatment of:adjuvant colon cancermetastatic colorectal cancermetastatic breast cancer. Detailed product information for the Medical Professional is available at https://www.gene.com/patients/medicines/xeloda
Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed product information for the Medical Professional is available at https://www.us.afinitor.com/
Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed product information for the Medical Professional is available at https://www.us.afinitor.com/
Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed product information for the Medical Professional is available at https://www.us.afinitor.com/
Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed product information for the Medical Professional is available at https://www.us.afinitor.com/
Tivdak (tisotumab vedotin-tftv) is a prescription medicine used to treat adults with recurrent or metastatic cervical cancer. Detailed product information for the Medical Professional is available at https://www.seagen.com/medicines/tivdak
Jemperli (dostarlimab) is a prescription medicine used to treat:Certain types of endometrial cancer (cancer of the womb) that are advanced or recurrent.Certain types of recurrent or advanced solid tumours.
Lynparza (olaparib) is a medication used for the treatment of ovarian, fallopian tube, primary peritoneal cancer, prostate cancer, prostate cancer and breast cancer. Detailed product information for the Medical Professional is available at https://www.lynparza.com/what-is-lynparza.html
Rubraca (rucaparib) is a medication used for the treatment of ovarian, fallopian tube and primary peritoneal cancer. Detailed product information for the Medical Professional is available at https://www.rubraca.com/
Rubraca (rucaparib) is a medication used for the treatment of ovarian, fallopian tube and primary peritoneal cancer. Detailed product information for the Medical Professional is available at https://www.rubraca.com/
Zejula (niraparib) is a medication used for the treatment of recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. Detailed product information for the Medical Professional is available at https://zejula.com/
Xeloda (capecitabine) is indicated for the treatment of:adjuvant colon cancermetastatic colorectal cancermetastatic breast cancer. Detailed product information for the Medical Professional is available at www.gene.com/patients/medicines/xeloda
Stivarga is a medicine used to treat colon or rectal cancer (CRC), gastrointestinal stromal tumor (GIST), and hepatocellular carcinoma (HCC). Detailed product information for the Medical Professional is available at https://www.stivarga-us.com/
Braftovi (encorafenib) is a prescription medicine used for treating certain cancers when their cells have a mutation (change) in their genes called 'BRAF V600'. Detailed product information for the Medical Professional is available at www.braftovimektovi.com/
Braftovi (encorafenib) is a prescription medicine used for treating certain cancers when their cells have a mutation (change) in their genes called 'BRAF V600'. Detailed product information for the Medical Professional is available at www.braftovimektovi.com/
Braftovi (encorafenib) is a prescription medicine used for treating certain cancers when their cells have a mutation (change) in their genes called 'BRAF V600'. Detailed product information for the Medical Professional is available at www.braftovimektovi.com/
Braftovi (encorafenib) is a prescription medicine used for treating certain cancers when their cells have a mutation (change) in their genes called 'BRAF V600'. Detailed product information for the Medical Professional is available at www.braftovimektovi.com/
Cyramza (ramucirumab) is a medication used for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma, metastatic non small cell lung cancer, and metastatic colorectal cancer. Detailed product information for the Medical Professional is available at https://www.cyramza.com/
Cyramza (ramucirumab) is a medication used for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma, metastatic non small cell lung cancer, and metastatic colorectal cancer. Detailed product information for the Medical Professional is available at https://www.cyramza.com/
Keytruda (pembrolizumab) is a medication used for the treatment of advanced melanoma, metastatic nonsquamous NSCLC, recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC), recurrent classical Hodgkin Lymphoma (cHL), locally advanced or metastatic urothelial carcinoma, solid tumours having the biomarkers MSI-H or dMMR, recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, triple-negative breast cancer. Detailed product information for the Medical Professional is available at https://www.keytruda.com/
Lonsurf (trifluridine / tipiracil) is a medication used for the treatment of advanced (metastatic) colorectal cancer. Detailed product information for the Medical Professional is available at https://www.lonsurf.com/
Lonsurf (trifluridine / tipiracil) is a medication used for the treatment of advanced (metastatic) colorectal cancer. Detailed product information for the Medical Professional is available at https://www.lonsurf.com/
Opdivo (nivolumab) is a medication used for the treatment of certain types of cancer. Detailed product information for the Medical Professional is available at https://www.opdivo.com/
Opdivo (nivolumab) is a medication used for the treatment of certain types of cancer. Detailed product information for the Medical Professional is available at https://www.opdivo.com/
Enhertu (fam-trastuzumab deruxtecan-nxki) is a medication used for the treatment of adult patients with advanced HER+ breast cancer or with advanced HER2+ stomach (gastric) or gastroesophageal junction (GEJ) cancer. Detailed product information for the Medical Professional is available at https://www.enhertuhcp.com/en
Qinlock is a medication used for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST), who have received different types of treatment with 3 or more kinase inhibitors, including imatinib, sunitinib and regorafenib. Detailed product information for the Medical Professional is available at https://www.qinlock.com/
Cyramza (ramucirumab) is a medication used for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma, metastatic non small cell lung cancer, and metastatic colorectal cancer. Detailed product information for the Medical Professional is available at https://www.cyramza.com/
Cyramza (ramucirumab) is a medication used for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma, metastatic non small cell lung cancer, and metastatic colorectal cancer. Detailed product information for the Medical Professional is available at https://www.cyramza.com/
Keytruda (pembrolizumab) is a medication used for the treatment of advanced melanoma, metastatic nonsquamous NSCLC, recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC), recurrent classical Hodgkin Lymphoma (cHL), locally advanced or metastatic urothelial carcinoma, solid tumours having the biomarkers MSI-H or dMMR, recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, triple-negative breast cancer. Detailed product information for the Medical Professional is available at https://www.keytruda.com/
AFINITOR (EVEROLIMUS)Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed product information for the Medical Professional is available at https://www.us.afinitor.com/
AFINITOR (EVEROLIMUS)Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed product information for the Medical Professional is available at https://www.us.afinitor.com/
AFINITOR (EVEROLIMUS)Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed product information for the Medical Professional is available at https://www.us.afinitor.com/
AFINITOR (EVEROLIMUS)Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed product information for the Medical Professional is available at https://www.us.afinitor.com/
Ayvakit (avapritinib) is a medication for the treatment of people with advanced cases of gastrointestinal stromal tumor (GIST) that have a genetic mutation in exon 18. Detailed product information for the Medical Professional is available at https://ayvakit.com/
Ayvakit (avapritinib) is a medication for the treatment of people with advanced cases of gastrointestinal stromal tumor (GIST) that have a genetic mutation in exon 18. Detailed product information for the Medical Professional is available at https://ayvakit.com/
Ayvakit (avapritinib) is a medication for the treatment of people with advanced cases of gastrointestinal stromal tumor (GIST) that have a genetic mutation in exon 18. Detailed product information for the Medical Professional is available at https://ayvakit.com/
AFINITOR (EVEROLIMUS)Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed product information for the Medical Professional is available at https://www.us.afinitor.com/
AFINITOR (EVEROLIMUS)Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed product information for the Medical Professional is available at https://www.us.afinitor.com/
AFINITOR (EVEROLIMUS)Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed product information for the Medical Professional is available at https://www.us.afinitor.com/
AFINITOR (EVEROLIMUS)Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed product information for the Medical Professional is available at https://www.us.afinitor.com/
Keytruda (pembrolizumab) is a medication used for the treatment of advanced melanoma, metastatic nonsquamous NSCLC, recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC), recurrent classical Hodgkin Lymphoma (cHL), locally advanced or metastatic urothelial carcinoma, solid tumours having the biomarkers MSI-H or dMMR, recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, triple-negative breast cancer. Detailed product information for the Medical Professional is available at https://www.keytruda.com/
Opdivo (nivolumab) is a medication used for the treatment of certain types of cancer. Detailed product information for the Medical Professional is available at https://www.opdivo.com/
Opdivo (nivolumab) is a medication used for the treatment of certain types of cancer. Detailed product information for the Medical Professional is available at https://www.opdivo.com/
Besponsa (inotuzumab ozogamicin) is is a medication used for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Detailed product information for the Medical Professional is available at besponsa.pfizerpro.com/
Scemblix (asciminib) is a prescription medication used to treat adults with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). Detailed product information for the Medical Professional is available at https://www.hcp.novartis.com/products/scemblix/ph-cml/
Daurismo (glasdegib) is a prescription medicine that is used with the medicine cytarabine to treat adults with newly-diagnosed acute myeloid leukaemia (AML). Detailed product information for the Medical Professional is available at https://daurismo.pfizerpro.com/
Xospata (gilteritinib) is a medication used with other medicines to treat adults with FLT3m+ AML when the disease has come back or has not improved after previous treatment(s). Detailed product information for the Medical Professional is available at https://xospata.com/
Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) is a prescription medicine that is a component of a multi-agent chemotherapeutic regimen used to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adults and children aged 1 month or older who have developed hypersensitivity to E. coli-derived asparaginase. Detailed product information for the Medical Professional is available at https://www.rylaze.com/
Jakavi (ruxolitinib) is a prescription medicine used to treat adults with myelofibrosis (MF), Polycythaemia vera (PV), or adult and pediatric patients 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD. Detailed product information for the Medical Professional is available at https://www.jakavi.com/
Jakavi (ruxolitinib) is a prescription medicine used to treat adults with myelofibrosis (MF), Polycythaemia vera (PV), or adult and pediatric patients 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD. Detailed product information for the Medical Professional is available at https://www.jakavi.com/
Jakavi (ruxolitinib) is a prescription medicine used to treat adults with myelofibrosis (MF), Polycythaemia vera (PV), or adult and pediatric patients 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD. Detailed product information for the Medical Professional is available at https://www.jakavi.com/
Jakavi (ruxolitinib) is a prescription medicine used to treat adults with myelofibrosis (MF), Polycythaemia vera (PV), or adult and pediatric patients 12 years and older with steroid-refractory acute graft-versus-host disease (GVHD) or chronic GVHD. Detailed product information for the Medical Professional is available at https://www.jakavi.com/
Lumoxiti (moxetumomab pasudotox) is a CD22-directed cytotoxin indicated for adult patients with advanced hairy cell leukemia (HCL) who received at least two prior systemic therapies, including treatment with a purine nucleoside analog (PNA). Detailed product information for the Medical Professional is available at https://www.lumoxiti.com/
Lumoxiti (moxetumomab pasudotox) is a CD22-directed cytotoxin indicated for adult patients with advanced hairy cell leukemia (HCL) who received at least two prior systemic therapies, including treatment with a purine nucleoside analog (PNA). Detailed product information for the Medical Professional is available at https://www.lumoxiti.com/
Asparlas (calaspargase pegol-mknl) is a component of a multiagent chemotherapeutic regimen for the treatment of Acute Lymphoblastic Leukemia (ALL) in pediatric and young adult patients aged 1 month to 21 years. Detailed product information for the Medical Professional is available at https://asparlas.com/
Elzonris (tagraxofusp-erzs) is a medication used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older. Detailed product information for the Medical Professional is available at https://www.elzonris.com/
Onureg (azacitidine) is a medication used for the continued treatment of adults with acute myeloid leukemia (AML). Detailed product information for the Medical Professional is available at https://www.onuregpro.com/
Onureg (azacitidine) is a medication used for the continued treatment of adults with acute myeloid leukemia (AML). Detailed product information for the Medical Professional is available at https://www.onuregpro.com/
Inqovi (decitabine and cedazuridine) is a medication used for the treatment of adults with myelodysplastic syndromes (MDS), including chronic myelomonocytic leukemia (CMML). Detailed product information for the Medical Professional is available at https://www.inqovi.com/
Tibosovo (ivosidenib) is a prescription medicine used to treat adults with an IDH1 mutation who have:Acute myeloid leukemia (AML) that is either newly-diagnosed or relapsed/refractory, orLocally advanced or metastatic bile duct cancer (cholangiocarcinoma) Detailed product information for the Medical Professional is available at https://www.tibsovo.com/
Copiktra (duvelisib) is a medication used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and follicular lymphoma (FL) after at least two prior therapies. Detailed product information for the Medical Professional is available at https://copiktra.com/
Copiktra (duvelisib) is a medication used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and follicular lymphoma (FL) after at least two prior therapies. Detailed product information for the Medical Professional is available at https://copiktra.com/
Tasigna (nilotinib) is a prescription medicine used to treat chronic myelogenous leukaemia (CML) in patients who have the Philadelphia chromosome. It may be used in people who have been newly diagnosed or who cannot take other cancer medicines (including imatinib). Detailed product information for the Medical Professional is available at https://www.us.tasigna.com/
Tasigna (nilotinib) is a prescription medicine used to treat chronic myelogenous leukaemia (CML) in patients who have the Philadelphia chromosome. It may be used in people who have been newly diagnosed or who cannot take other cancer medicines (including imatinib). Detailed product information for the Medical Professional is available at https://www.us.tasigna.com/
Tasigna (nilotinib) is a prescription medicine used to treat chronic myelogenous leukaemia (CML) in patients who have the Philadelphia chromosome. It may be used in people who have been newly diagnosed or who cannot take other cancer medicines (including imatinib). Detailed product information for the Medical Professional is available at https://www.us.tasigna.com/
Venclexta/Venclyxto (venetoclax) is a medication used for the treatment of adult patients with Chronic Lymphocytic Leukemia (CLL) or in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia (AML). Detailed product information for the Medical Professional is available at https://www.venclexta.com/
Venclexta/Venclyxto (venetoclax) is a medication used for the treatment of adult patients with Chronic Lymphocytic Leukemia (CLL) or in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia (AML). Detailed product information for the Medical Professional is available at https://www.venclexta.com/
Venclexta/Venclyxto (venetoclax) is a medication used for the treatment of adult patients with Chronic Lymphocytic Leukemia (CLL) or in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia (AML). Detailed product information for the Medical Professional is available at https://www.venclexta.com/
Exkivity (mobocertinib) is a medication used with other medicines to treat adults with locally advanced or metastatic EGFR Exon20 Insertion+ Non-Small Cell Lung Cancer (NSCLC). Detailed information of the product for the medical professional is available at https://www.exkivity.com/
Verzenio (abemaciclib) is a medication indicated for the treatment of women with HR-positive, HER2-negative advanced or metastatic breast cancer. Detailed product information for the Medical Professional is available at https://www.verzenio.com/
Nerlynx (neratinib) is a medication indicated for the adjuvant treatment of adult patients with early-stage HER2 positive overexpressed/amplified breast cancer. Detailed product information for the Medical Professional is available at https://nerlynx.com/
Piqray (alpelisib) is a medication used in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CAmutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen. Detailed product information for the Medical Professional is available at https://www.hcp.novartis.com/products/piqray/metastatic-breast-cancer/
Piqray (alpelisib) is a medication used in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CAmutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen. Detailed product information for the Medical Professional is available at https://www.hcp.novartis.com/products/piqray/metastatic-breast-cancer/
Exkivity (mobocertinib) is a medication used with other medicines to treat adults with locally advanced or metastatic EGFR Exon20 Insertion+ Non-Small Cell Lung Cancer (NSCLC). Detailed information of the product for the medical professional is available at https://www.exkivity.com/
Rybrevant (amivantamab-vmjw) is a prescription medicine used to treat adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that have EGFR exon 20 insertion mutations. Detailed information of the product for the medixcal professional is available at https://www.rybrevant.com/
Xalkori (crizotinib) is a prescription medicine used to treat people with metastatic non-small cell lung cancer (NSCLC), that is either ALK-positive or ROS1-positive, or people with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive. Detailed information of the product for the medixcal professional is available at www.xalkori.com/
Xalkori (crizotinib) is a prescription medicine used to treat people with metastatic non-small cell lung cancer (NSCLC), that is either ALK-positive or ROS1-positive, or people with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive. Detailed information of the product for the medixcal professional is available at www.xalkori.com/
Rydapt (midostaurin) is a medication used for the treatment of patients with newly diagnosed acute myeloid leukemia (AML), aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL). Detailed product information for the Medical Professional is available at https://www.us.rydapt.com/
Cosela (trilaciclib) is a medication to reduce the damage done on the bone marrow by chemotherapy (myelosuppression) in adult patients with extensive-stage small cell lung cancer (ES-SCLC) prior to receiving chemotherapy. Detailed information of the product for the medixcal professional is available at https://www.cosela.com/
Truxima (rituximab) is a medication used for the treatment of follicular lymphoma and diffuse large B-cell Non-Hodgkin’s Lymphoma (NHL); chronic lymphocytic leukemia (CLL); severe active rheumatoid arthritis and granulomatosis with polyangiitis and microscopic polyangiitis. Detailed product information for the Medical Professional is available at https://www.truxima.com/
Truxima (rituximab) is a medication used for the treatment of follicular lymphoma and diffuse large B-cell Non-Hodgkin’s Lymphoma (NHL); chronic lymphocytic leukemia (CLL); severe active rheumatoid arthritis and granulomatosis with polyangiitis and microscopic polyangiitis. Detailed product information for the Medical Professional is available at https://www.truxima.com/
Gavreto (pralsetinib) is a medication used for the treatment of adults with metastatic RET fusion-positive non-small cell lung cancer (NSCLC) and adults with advanced or metastatic thyroid cancer. Detailed information of the product for the medixcal professional is available at https://www.gavreto.com/
Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) is a prescription medicine that is a component of a multi-agent chemotherapeutic regimen used to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adults and children aged 1 month or older who have developed hypersensitivity to E. coli-derived asparaginase. Detailed product information for the Medical Professional is available at https://www.rylaze.com/
Retevmo (selpercatinib) is a medication used for the treatment of lung and thyroid cancers with a genetic mutation or fusion in the RET gene. It is the first treatment option available for patients with an abnormal RET gene. Detailed information of the product for the medixcal professional is available at https://www.retevmo.com/
Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) is a prescription medicine that is a component of a multi-agent chemotherapeutic regimen used to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adults and children aged 1 month or older who have developed hypersensitivity to E. coli-derived asparaginase. Detailed product information for the Medical Professional is available at https://www.rylaze.com/
Retevmo (selpercatinib) is a medication used for the treatment of lung and thyroid cancers with a genetic mutation or fusion in the RET gene. It is the first treatment option available for patients with an abnormal RET gene. Detailed information of the product for the medixcal professional is available at https://www.retevmo.com/
Zynlonta (loncastuximab tesirine-lpyl) is a prescription medicine used to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after at least 2 prior systemic therapies.
Retevmo (selpercatinib) is a medication used for the treatment of lung and thyroid cancers with a genetic mutation or fusion in the RET gene. It is the first treatment option available for patients with an abnormal RET gene. Detailed information of the product for the medixcal professional is available at https://www.retevmo.com/
Xalkori (crizotinib) is a prescription medicine used to treat people with metastatic non-small cell lung cancer (NSCLC), that is either ALK-positive or ROS1-positive, or people with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive. Detailed product information for the Medical Professional is available at https://www.xalkori.com/
Tabrecta (capmatinib) is a medication used for the treatment of adults with metastatic NSCLC with a mutation that leads to MET exon 14 skipping (METex14). (Detailed information of the product for the medical professional is available at www.us.tabrecta.com/met-exon-14-skipping-mutation-nsclc/
Xalkori (crizotinib) is a prescription medicine used to treat people with metastatic non-small cell lung cancer (NSCLC), that is either ALK-positive or ROS1-positive, or people with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive. Detailed product information for the Medical Professional is available at https://www.xalkori.com/
Tabrecta (capmatinib) is a medication used for the treatment of adults with metastatic NSCLC with a mutation that leads to MET exon 14 skipping (METex14). (Detailed information of the product for the medical professional is available at https://www.us.tabrecta.com/met-exon-14-skipping-mutation-nsclc/
Ukoniq (umbralisib) is a medication used for the treatment of adult patients with subtypes of Non-Hodgkin Lymphoma, namely relapsed or refractory marginal zone lymphoma (MZL) and relapsed or refractory follicular lymphoma (FL). Detailed product information for the Medical Professional is available at https://ukoniq.com/
Zepzelca (lurbinectedin) is a medication used for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy. (Detailed information of the product for the medical professional is available at www.zepzelca.com/
Reblozyl (luspatercept) is a medication used for the treatment of adults with anemia (low red blood cells) associated with beta thalassemia or myelodysplastic syndromes. Detailed product information for the Medical Professional is available at https://www.reblozyl.com/
Lorviqua (lorlatinib) is a medicine indicated for the treatment of previously treated patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC).
Xpovio (selinexor) is a medication used for the treatment of patients with relapsed/refractory multiple myeloma or diffuse large B-cell lymphoma. Detailed product information for the Medical Professional is available at https://www.xpovio.com/
Lorviqua (lorlatinib) is a medicine indicated for the treatment of previously treated patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC).
Xpovio (selinexor) is a medication used for the treatment of patients with relapsed/refractory multiple myeloma or diffuse large B-cell lymphoma. Detailed product information for the Medical Professional is available at https://www.xpovio.com/
Vizimpro (dacomitinib) is a medication used for the treatment of patients with metastatic NSCLC with EGFR exon 19 deletion or exon 21 L858R substitution mutations. (Detailed information of the product for the medical professional is available at https://www.vizimpro.com/
Monjuvi (tafasitamab-cxix) is a medication that is combined with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Detailed product information for the Medical Professional is available at https://www.monjuvi.com/
Vizimpro (dacomitinib) is a medication used for the treatment of patients with metastatic NSCLC with EGFR exon 19 deletion or exon 21 L858R substitution mutations. (Detailed information of the product for the medical professional is available at https://www.vizimpro.com/
Velexbru (tirabrutinib hydrochloride) is a medication used for the treatment of recurrent or refractory primary central nervous system lymphoma.
Vizimpro (dacomitinib) is a medication used for the treatment of patients with metastatic NSCLC with EGFR exon 19 deletion or exon 21 L858R substitution mutations. (Detailed information of the product for the medical professional is available at https://www.vizimpro.com/
Polivy (polatuzumab vedotin-piiq) is a medication indicated in combination with bendamustine and a rituximab product for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified, after at least two prior therapies. Diffuse large B-cell lymphoma is a type of non-Hodgkin lymphoma. Detailed product information for the Medical Professional is available at https://www.polivy.com/
Cyramza (ramucirumab) is a medication used for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma, metastatic non small cell lung cancer, and metastatic colorectal cancer. (Detailed information of the product for the medical professional is available at https://www.cyramza.com/
Calquence (acalabrutinib) is a medication used for the treatment of Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukaemia (CLL) and Small Lymphocytic Leukaemia (SLL). Detailed product information for the Medical Professional is available at https://www.calquence.com/
Cyramza (ramucirumab) is a medication used for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma, metastatic non small cell lung cancer, and metastatic colorectal cancer. (Detailed information of the product for the medical professional is available at https://www.cyramza.com/
Copiktra (duvelisib) is a medication used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and follicular lymphoma (FL) after at least two prior therapies. Detailed product information for the Medical Professional is available at https://copiktra.com/
Alecensa (alectinib) is a medication used for the treatment of anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer (NSCLC). (Detailed information of the product for the medical professional is available at https://www.alecensa.com/
Copiktra (duvelisib) is a medication used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and follicular lymphoma (FL) after at least two prior therapies. Detailed product information for the Medical Professional is available at https://copiktra.com/
ALUNBRIG (Brigatinib) is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC):that has a certain type of abnormal anaplastic lymphoma kinase (ALK) gene, andthat has spread to other parts of your body. (Detailed information of the product for the medical professional is available at https://www.alunbrig.com/
Poteligeo (mogamulizumab) is a medication used to treat adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy. Detailed product information for the Medical Professional is available at https://poteligeo.com/
ALUNBRIG (Brigatinib) is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC):that has a certain type of abnormal anaplastic lymphoma kinase (ALK) gene, andthat has spread to other parts of your body. (Detailed information of the product for the medical professional is available at https://www.alunbrig.com/
Adcetris (brentuximab vedotin) is a prescription medicine used to treat adults with certain lymphomas that are CD30-positive. Detailed information of the product for the medical professional is available at https://www.adcetris.com/
ALUNBRIG (Brigatinib) is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC):that has a certain type of abnormal anaplastic lymphoma kinase (ALK) gene, andthat has spread to other parts of your body. (Detailed information of the product for the medical professional is available at https://www.alunbrig.com/
Aliqopa (copanlisib) is a medication used for the treatment of relapsed follicular lymphoma. Detailed information of the product for the medical professional is available at https://www.aliqopa-us.com/
Keytruda (pembrolizumab) is a medication used for the treatment of advanced melanoma, metastatic nonsquamous NSCLC, recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC), recurrent classical Hodgkin Lymphoma (cHL), locally advanced or metastatic urothelial carcinoma, solid tumours having the biomarkers MSI-H or dMMR, recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, triple-negative breast cancer. (Detiled information of the product for the medical professional is available at www.keytruda.com/
Belinostat is is a medication used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Detailed information of the product for the medical professional is available at https://beleodaq.com/#!/
(Detiled information of the product for the medical professional is available at www.opdivo.com/
Keytruda (pembrolizumab) is a medication used for the treatment of advanced melanoma, metastatic nonsquamous NSCLC, recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC), recurrent classical Hodgkin Lymphoma (cHL), locally advanced or metastatic urothelial carcinoma, solid tumours having the biomarkers MSI-H or dMMR, recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, triple-negative breast cancer. Detailed information of the product for the medical professional is available at www.keytruda.com/
Opdivo (nivolumab) is a medication used for the treatment of certain types of cancer. (Detiled information of the product for the medical professional is available at www.opdivo.com/
Opdivo (nivolumab) is a medication used for the treatment of certain types of cancer. Detailed information of the product for the medical professional is available at www.keytruda.com/
Portrazza (necitumumab) is a medication used for the treatment of metastatic squamous non-small cell lung cancer.
Opdivo (nivolumab) is a medication used for the treatment of certain types of cancer. Detailed information of the product for the medical professional is available at www.keytruda.com/
Tagrisso (osimertinib) is a medicine for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with a T790M mutation in the epidermal growth factor receptor (EGFR) gene.
Tecentriq (atezolizumab) is a medication used for the treatment of locally advanced or metastatic urothelial carcinoma, for the treatment of metastatic non-small cell lung cancer (NSCLC), and for the treatment of advanced triple negative breast cancer (TNBC).
Libtayo (cemiplimab) is a medication used for the treatment of advanced cutaneous squamous cell carcinoma (CSCC), advanced basal cell carcinoma (BCC) and advanced non-small cell lung cancer (NSCLC).
Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed information of the product for the medical professional is available at www.us.afinitor.com/
Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed information of the product for the medical professional is available at www.us.afinitor.com/
Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed information of the product for the medical professional is available at www.us.afinitor.com/
Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis. Detailed information of the product for the medical professional is available at www.us.afinitor.com/
Sarclisa (isatuximab) is a medication used in combination with pomalidomide and dexamethasone or with carfilzomib and dexamethasone for the treatment of adults with relapsed refractory multiple myeloma (RRMM). Detailed information of the product for the medical professional is available at www.sarclisa.com/
Sarclisa (isatuximab) is a medication used in combination with pomalidomide and dexamethasone or with carfilzomib and dexamethasone for the treatment of adults with relapsed refractory multiple myeloma (RRMM). Detailed information of the product for the medical professional is available at www.sarclisa.com/
Xpovio (selinexor) is a medication used for the treatment of patients with relapsed/refractory multiple myeloma or diffuse large B-cell lymphoma. Detailed information of the product for the medical professional is available at www.xpovio.com/
Xpovio (selinexor) is a medication used for the treatment of patients with relapsed/refractory multiple myeloma or diffuse large B-cell lymphoma. Detailed information of the product for the medical professional is available at www.xpovio.com/
Blenrep (belantamab mafodotin-blmf) is a medication used for the treatment of adult patients with relapsed or refractory multiple myeloma whose disease has progressed despite prior treatment with an immunomodulatory agent, proteasome inhibitor and anti-CD38 antibody. Detailed information of the product for the medical professional is available at www.blenrep.com/
Accrufer (ferric maltol) is a medication used for the treatment of iron deficiency with or without anemia in adults.
Truseltiq (infigratinib) is a prescription medicine used to treat previously-treated locally advanced or metastatic bile duct cancer (cholangiocarcinoma). Detailed information of the product for the medical professional is available at www.truseltiq.com/
Darzalex (daratumumab) is a medication used for the treatment of multiple myeloma. Detailed information of the product for the medical professional is available at www.darzalex.com/
Reblozyl (luspatercept) is a medication used for the treatment of adults with anemia (low red blood cells) associated with beta thalassemia or myelodysplastic syndromes.( Detailed product in formation for the medical professional is available at https://www.reblozyl.com/
Darzalex (daratumumab) is a medication used for the treatment of multiple myeloma. Detailed information of the product for the medical professional is available at www.darzalex.com/
Inrebic (fedratinib) is a medication used for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.( Detailed product in formation for the medical professional is available at www.inrebic.com/
Pemazyre (pemigatinib) is a medication used for the treatment of adult patients with bile duct cancer (cholangiocarcinoma) that has spread or cannot be removed by surgery. Detailed Information of the product for the Medical Professional is available at https://www.pemazyre.com/
Empliciti (elotuzumab) is a medication, used in combination with lenalidomide and dexamethasone, for the treatment of multiple myeloma in patients who have received one to three prior therapies. Detailed information of the product for the medical professional is available at https://www.empliciti.com/EMPLICITI (ELOTUZUMAB)
Besremi (ropeginterferon alfa-2b) is a medication used to treat Polycythaemia Vera (PV) in adult patients.( Detailed Product Information for the Medical Professional is available at https://www.aop-health.com/at_en/individual-treatments/hematooncology/besremi-1
Empliciti (elotuzumab) is a medication, used in combination with lenalidomide and dexamethasone, for the treatment of multiple myeloma in patients who have received one to three prior therapies. Detailed information of the product for the medical professional is available at https://www.empliciti.com/
Adakveo (crizanlizumab) is a medication used to prevent painful crises in patients with sickle cell disease aged 16 years and older.It is the first targeted therapy approved for sickle cell disease.(Detailed Product Information for the Medical Professional is available on https://www.us.adakveo.com/sickle-cell-disease/ )
Pemazyre (pemigatinib) is a medication used for the treatment of adult patients with bile duct cancer (cholangiocarcinoma) that has spread or cannot be removed by surgery. Detailed Information of the product for the Medical Professional is available at https://www.pemazyre.com/
Ninlaro (ixazomib) is a medication used for the treatment of multiple myeloma. Detailed information of the product for the medical professional is available at www.ninlaro.com/
Oxbryta (voxelotor) is a hemoglobin S polymerization inhibitor indicated for the treatment of sickle cell disease in adults and children 12 years of age and older.(Detailed Product Information for the Medical Professional is available on https://www.oxbryta.com/
Ninlaro (ixazomib) is a medication used for the treatment of multiple myeloma. Detailed information of the product for the medical professional is available at www.ninlaro.com/
Ondexxya (andexanet alfa) is a medication used for the treatment of patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.This is the first approved antidote for apixaban- or rivaroxaban-treated patients with uncontrolled bleeds.
Pemazyre (pemigatinib) is a medication used for the treatment of adult patients with bile duct cancer (cholangiocarcinoma) that has spread or cannot be removed by surgery. Detailed Information of the product for the Medical Professional is available at https://www.pemazyre.com/
Ninlaro (ixazomib) is a medication used for the treatment of multiple myeloma. Detailed information of the product for the medical professional is available at www.ninlaro.com/
Ondexxya (andexanet alfa) is a medication used for the treatment of patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.This is the first approved antidote for apixaban- or rivaroxaban-treated patients with uncontrolled bleeds.
Libtayo (cemiplimab) is a medication used for the treatment of advanced cutaneous squamous cell carcinoma (CSCC), advanced basal cell carcinoma (BCC) and advanced non-small cell lung cancer (NSCLC). ( Detailed product in formation for the medical professional is available at https://www.libtayo.com/
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) is a medication used for the treatment of patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.This is the first approved antidote for apixaban- or rivaroxaban-treated patients with uncontrolled bleeds.(Detailed product information for the medical professional is available on https://www.andexxa.com/
Tibosovo (ivosidenib) is a prescription medicine used to treat adults with an IDH1 mutation who have:Acute myeloid leukemia (AML) that is either newly-diagnosed or relapsed/refractory, orLocally advanced or metastatic bile duct cancer (cholangiocarcinoma). Detailed Information of the product for the Medical Professional is available at https://www.tibsovo.com/
Yervoy (ipilimumab) is a kinase inhibitor indicated for the treatment of:- advanced (unresectable or metastatic) melanoma - cutaneous melanoma- previously untreated advanced renal cell carcinoma- microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) is a medication used for the treatment of patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.This is the first approved antidote for apixaban- or rivaroxaban-treated patients with uncontrolled bleeds.Detailed product information is available on https://www.andexxa.com/
Braftovi (encorafenib) is a prescription medicine used for treating certain cancers when their cells have a mutation (change) in their genes called 'BRAF V600'. ( Detailed product in formation for the medical professional is available at https://www.braftovimektovi.com/
Opdivo (nivolumab) is a medication used for the treatment of certain types of cancer. Detailed Information of the product for the Medical Professional is available at www.opdivo.com/
Braftovi (encorafenib) is a prescription medicine used for treating certain cancers when their cells have a mutation (change) in their genes called 'BRAF V600'. ( Detailed product in formation for the medical professional is available at https://www.braftovimektovi.com/
Braftovi (encorafenib) is a prescription medicine used for treating certain cancers when their cells have a mutation (change) in their genes called 'BRAF V600'. ( Detailed product in formation for the medical professional is available at https://www.braftovimektovi.com/
Opdivo (nivolumab) is a medication used for the treatment of certain types of cancer. Detailed Information of the product for the Medical Professional is available at www.opdivo.com/
Braftovi (encorafenib) is a prescription medicine used for treating certain cancers when their cells have a mutation (change) in their genes called 'BRAF V600'. ( Detailed product in formation for the medical professional is available at https://www.braftovimektovi.com/
Mektovi (binimetinib) is indicated in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation1,2.
Lenvima (lenvatinib) is a prescription medicine used to treat patients with inoperable liver cancer, differentiated thyroid cancer, advanced kidney cancer and thymic cancer. Detailed Information of the product for the Medical Professional is available at www.lenvima.com/
Bavencio (avelumab) is a medication used for the treatment of metastatic Merkel cell carcinoma (MCC), locally advanced or metastatic urothelial carcinoma, and renal cell carcinoma (RCC). ( Detailed product in formation for the medical professional is available at www.bavencio.com/hcp
COTELLIC (cobimetinib) is indicated for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, in combination with ZELBORAF (vemurafenib). ( Detailed product in formation for the medical professional is available at https://www.cotellic.com/
Lenvima (lenvatinib) is a prescription medicine used to treat patients with inoperable liver cancer, differentiated thyroid cancer, advanced kidney cancer and thymic cancer.
Keytruda (pembrolizumab) is a medication used for the treatment of advanced melanoma, metastatic nonsquamous NSCLC, recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC), recurrent classical Hodgkin Lymphoma (cHL), locally advanced or metastatic urothelial carcinoma, solid tumours having the biomarkers MSI-H or dMMR, recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, triple-negative breast cancer. ( Detailed product in formation for the medical professional is available at https://www.keytruda.com/
Odomzo (sonidegib) is a medication for the treatment of locally advanced basal cell carcinoma (BCC) that cannot be treated with surgery or radiation therapy. ( Detailed product in formation for the medical professional is available at www.odomzo.com/
ONIVYDE is a topoisomerase inhibitor indicated, in combination withfluorouracil and leucovorin, for the treatment of patients with metastaticadenocarcinoma of the pancreas after disease progression followinggemcitabine-based therapy. ONIVYDE is not indicated as a single agent for thetreatment of patients with metastatic adenocarcinoma of the pancreas.
Opdivo (nivolumab) is a medication used for the treatment of certain types of cancer. ( Detailed product in formation for the medical professional is available at https://www.opdivo.com/
Opdivo (nivolumab) is a medication used for the treatment of certain types of cancer. ( Detailed product in formation for the medical professional is available at www.opdivo.com/
Imfinzi (durvalumab) is a medication used for the treatment of locally advanced or metastatic urothelial carcinoma (bladder cancer) and unresectable, stage III non-small cell lung cancer (NSCLC). Detailed information of the product for the medical professional is available at https://www.imfinzi.com/
Tazverik (tazemetostat) is a medication used for the treatment of epithelioid sarcoma that is locally advanced (when the cancer is growing outside of the organ, but has not yet spread) or metastasized (when cancer cells have spread to other parts of the body) and that cannot be completely removed by surgery, and for relapsed or refractory follicular lymphoma.( Detailed product in formation for the medical professional is available at www.tazverik.com/
Ultomiris (ravulizumab) is a prescription medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria (PNH) and adults and children with atypical haemolytic uraemic syndrome (aHUS). ( Detailed product in formation for the medical professional is available at https://ultomiris.com/
Imfinzi (durvalumab) is a medication used for the treatment of locally advanced or metastatic urothelial carcinoma (bladder cancer) and unresectable, stage III non-small cell lung cancer (NSCLC). Detailed information of the product for the medical professional is available at https://www.imfinzi.com/
Ultomiris (ravulizumab) is a prescription medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria (PNH) and adults and children with atypical haemolytic uraemic syndrome (aHUS). ( Detailed product in formation for the medical professional is available at www.ultomiris.com/
Cablivi (caplacizumab) is a medicine approved for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP). It is available in powder form or solution for injection, to be used in combination with plasma exchange and immunosuppressive therapy. ( Detailed product in formation for the medical professional is available at www.cablivi.com/
Givlaari (givosiran) is a medication used for the treatment of adult patients and children aged 12 years and older with acute hepatic porphyria. ( Detailed product in formation for the medical professional is available at www.givlaari.com/
Tavneos (avacopan) is a prescription medicine used as an add-on treatment to standard therapy including glucocorticoids for adults with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. ( Detailed product in formation for the medical professional is available at www.tavneos.com/
Mircera (methoxy polyethylene glycol-epoetin beta) is a prescription medicine used for the treatment of anemia associated with chronic kidney disease (CKD). ( Detailed product in formation for the medical professional is available at www.mircera.com
Mircera (methoxy polyethylene glycol-epoetin beta) is a prescription medicine used for the treatment of anemia associated with chronic kidney disease (CKD). ( Detailed product in formation for the medical professional is available at www.mircera.com
Mircera (methoxy polyethylene glycol-epoetin beta) is a prescription medicine used for the treatment of anemia associated with chronic kidney disease (CKD). ( Detailed product in formation for the medical professional is available at www.mircera.com
Mircera (methoxy polyethylene glycol-epoetin beta) is a prescription medicine used for the treatment of anemia associated with chronic kidney disease (CKD). ( Detailed product in formation for the medical professional is available at mircera.com
Mircera (methoxy polyethylene glycol-epoetin beta) is a prescription medicine used for the treatment of anemia associated with chronic kidney disease (CKD). ( Detailed product in formation for the medical professional is available at https://mircera.com
Mircera (methoxy polyethylene glycol-epoetin beta) is a prescription medicine used for the treatment of anemia associated with chronic kidney disease (CKD). ( Detailed product in formation for the medical professional is available at https://mircera.com/
Mircera (methoxy polyethylene glycol-epoetin beta) is a prescription medicine used for the treatment of anemia associated with chronic kidney disease (CKD). ( Detailed product in formation for the medical professional is available at https://mircera.com
Mircera (methoxy polyethylene glycol-epoetin beta) is a prescription medicine used for the treatment of anemia associated with chronic kidney disease (CKD). ( Detailed product in formation for the medical professional is available at https://mircera.com
Evrenzo (roxadustat) is a medication used for the treatment of anemia associated with chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients.
Mircera (methoxy polyethylene glycol-epoetin beta) is a prescription medicine used for the treatment of anemia associated with chronic kidney disease (CKD). ( Detailed product in formation for the medical professional is available at https://mircera.com/
Evrenzo (roxadustat) is a medication used for the treatment of anemia associated with chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients.
Evrenzo (roxadustat) is a medication used for the treatment of anemia associated with chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients.
Evrenzo (roxadustat) is a medication used for the treatment of anemia associated with chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients.
Evrenzo (roxadustat) is a medication used for the treatment of anemia associated with chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients.
Feraccru (ferric maltol) is a medication used for the treatment of iron deficiency with or without anemia in adults.( Detailed product in formation for the medical professional is available at www.shieldtherapeutics.com/product/feraccru/
1 total
